IL-22/IL-22R1 axis and S100A8/A9 alarmins in human osteoarthritic and rheumatoid arthritis synovial fibroblasts

Rheumatology (United Kingdom)

Volumn 52, Issue 12, 2013, Pages 2177-2186

  Carrión, Mar ^a   Juarranz, Yasmina ^a   Martínez, Carmen ^a   González Álvaro, Isidoro ^b   Pablos, José L ^c   Gutiérrez Cañas, Irene ^a   Gomariz, Rosa P ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas   (Spain)

^c Instituto de Investigación Hospital 12 de Octubre ^*  (Spain)

Author keywords

Alarmins; IL 22; IL 22R1; Osteoarthritis; Rheumatoid arthritis; Synovial fibroblast

Indexed keywords

CALGRANULIN A; CALGRANULIN B; CYTOKINE; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 22; INTERLEUKIN 22 R 1; INTERLEUKIN 23; INTERLEUKIN 23P19; INTERSTITIAL COLLAGENASE; JANUS KINASE 2; JANUS KINASE 3; STAT3 PROTEIN; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; ELISA KIT; FIBROBLAST; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; MICROENVIRONMENT; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; UPREGULATION;

ALARMINS; IL-22; IL-22R1; OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; SYNOVIAL FIBROBLAST;

ARTHRITIS, RHEUMATOID; CALGRANULIN A; CALGRANULIN B; CELL PROLIFERATION; DOWN-REGULATION; FIBROBLASTS; HUMANS; HYPERPLASIA; INTERLEUKINS; JANUS KINASE 2; JANUS KINASE 3; MATRIX METALLOPROTEINASES; OSTEOARTHRITIS; PHOSPHORYLATION; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-17; STAT3 TRANSCRIPTION FACTOR; SYNOVIAL MEMBRANE; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84887686761     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ket315     Document Type: Article

References (42)

1. Ouyang W, Rutz S, Crellin NK et al. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu Rev Immunol 2011;29:71-109.
2. Wolk K, Witte E, Witte K et al. Biology of interleukin-22. Semin Immunopathol 2010;32:17-31.
3. Zenewicz LA, Flavell RA. Recent advances in IL-22 biology. Int Immunol 2011;23:159-63.
4. Sonnerberg GF, Fouse LA, Artis D. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat Immunol 2011;12:383-90.
5. Radaeva S, Sun R, Pan HN et al. Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 2004;39:1332-28.
6. Zenewicz LA, Yancopoulos GD, Valenzuela DM et al. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 2008;29:947-57.
7. Wolk K, Witte E, Wallace E et al. IL-22 regulates the expression of genes responsible for antimicrobial defence cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur J Immunol 2006;36:1309-23.
8. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003;423:356-61.
9. Bartok B, Firestein GS. Fibroblast-like synoviocytes:key effector cells in rheumatoid arthritis. Immunol Rev 2010;233:233-55.
10. Neumann E, Lefevre S, Zimmermann B et al. Rheumatoid arthritis progression mediated by activated synovial fibroblasts. Trends Mol Med 2010;16:458-68.
11. Ikeuchi H, Kuroiwa T, Hiramatsu N et al. Expression of IL-22 in rheumatoid arthritis. Arthritis Rheum 2005;52:1037-46.
12. Peńe J, Chevalier S, Preisser L et al. Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J Immunol 2008;180:7423-30.
13. Shen H, Goodall JC, Hill Gaston JS. Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum 2009;60:1647-56.
14. Colin EM, Asmawidjaja PS, van Hamburg JP et al. 1,25- dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis. Arthritis Rheum 2010;62:132-42.
15. Cascão R, Moura RA, Perpétuo I et al. Identification of a cytokine network sustaining neutrophil and Th17 activation in untreated early rheumatoid arthritis. Arthritis Res Ther 2010;12:R196.
16. Leipe J, Schramm MA, Grunke M et al. Interleukin 22 serum levels are associated with radiographic progression in rheumatoid arthritis. Ann Rheum Dis 2011;70:1453-7.
17. Geboes L, Dumoutier L, Kelchtermans H et al. Proinflammatory role of the Th17 cytokine interleukin-22 in collagen-induced arthritis in C57BL/6 mice. Arthritis Rheum 2009;60:390-5.
18. Sarkar S, Zhou X, Justa S et al. Interleukin-22 reduces the severity of collagen-induced arthritis in association with increased levels of interleukin-10. Arthritis Rheum 2013;65:960-71.
19. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
20. Murphy G, Nagase H. Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis:destruction or repair? Nat Clin Pract Rheumatol 2008;4:128-35.
21. Lubberts E. Th17 cytokines in arthritis. Semin Immunopathol 2010;32:43-53.
22. Hwang SY, Kim HY. Expression of IL-17 homologs and their receptors in the synovial cells of rheumatoid arthritis patients. Mol Cells 2005;19:180-4.
23. Kim HR, Cho ML, Kim KW et al. Up-regulation of IL-23p19 expression in rheumatoid arthritis synovial fibroblasts by IL-17 through PI3-kinase-, NF-kB- and p38 MAPKdependent signalling pathways. Rheumatology 2007;46:57-64.
24. Mitra A, Raychaudhuri S, Raychaudhuri SP. Functional role of IL-22 in psoriatic arthritis. Arthritis Res Ther 2012;14:R65.
25. Gutiérrez-Cañas I, Juarranz Y, Santiago B et al. VIP downregulates TLR4 expression and TLR4-mediated chemokine production in human rheumatoid synovial fibroblasts. Rheumatology 2006;45:527-32.
26. Carrión M, Juarranz Y, Pérez-García S et al. RNA sensors in human osteoarthritic and rheumatoid synovial fibroblasts. Immune regulation by vasoactive intestinal peptide. Arthritis Rheum 2011;63:1623-36.
27. Wolk K, Kunz S, Witte E et al. IL-22 increases the innate immunity of tissues. Immunity 2004;21:241-54.
28. Wolk K, Haugen HS, Xu W et al. IL-22 and IL-20 are key mediators on the epidermal alterations in psoriasis while IL-17 and IFN-g are not. J Mol Med 2009;87:523-36.
29. Xie MH, Aggarwal S, Ho WH et al. Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R. J Biol Chem 2000;275:31335-9.
30. van Lent PL, Grevers L, Blom AB et al. Myeloid-related proteins S100A8/S100A9 regulate joint inflammation and cartilage destruction during antigen-induced arthritis. Ann Rheum Dis 2008;67:1750-8.
31. van Lent PL, Blom AB, Schelbergen RF et al. Active involvement of alarmins S100A8 and S100A9 in the regulation of synovial activation and joint destruction during mouse and human osteoarthritis. Arthritis Rheum 2012;64:1466-76.
32. Vogl T, Tenbrok K, Ludwig S et al. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med 2007;13:1042-9.
33. Grevers LC, de Vries TJ, Vogl T et al. S100A8 enhances osteoclastic bone resorption in vitro through activation of Toll-like receptor 4. Arthritis Rheum 2011;63:1365-75.
34. Schelbergen RF, Blom AB, van den Bosch MH et al. Alarmins S100A8 and S100A9 elicit a catabolic effect in human osteoarthritic chondrocytes that is dependent on Toll-like receptor 4. Arthritis Rheum 2012;64:1477-87.
35. Kane D, Roth J, Frosch M et al. Increased perivascular synovial membrane expression of myeloid-related proteins in psoriatic arthritis. Arthritis Rheum 2003;48:1676-85.
36. Sunahori K, Yamamura M, Yamana J et al. The S100A8/A9 heterodimer amplifies proinflammatory cytokine production by macrophages via activation of nuclear factor kappa B and p38 mitogen-activated protein kinase in rheumatoid arthritis. Arthritis Res Ther 2006;8:R69.
37. Zreiqat H, Howlett CR, Gronthos S et al. S100A8/S100A9 and their association with cartilage and bone. J Mol Histol 2007;38:381-91.
38. Bromberg JF, Wrzeszczynska MH, Devgan G et al. Stat3 as an oncogene. Cell 1999;98:295-303.
39. Kim KW, Kim HR, Park JY et al. IL-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts. Arthritis Rheum 2012;64:1015-23.
40. Coombs JH, Bloom BJ, Breedveld FC et al. Improved pain, physical functioning and health status in patients with rheumatoid arthritis treated with CP-690,550, an orally active Janus kinase (JAK) inhibitor:results from a randomised, doubleblind, placebo-controlled trial. Ann Rheum Dis 2010;69:413-6.
41. Nistala K, Adams S, Cambrook H et al. Th17 plasticity in human autoimmune arthritis is driven by the inflammatory microenvironment. Proc Natl Acad Sci USA 2010;107:14751-6.
42. van Hamburg JP, Corneth OB, Paulissen SM et al. IL-17/Th17 mediated synovial inflammation is IL-22 independent. Ann Rheum Dis 2013;72:1700-7.